Nap protects against tau hyperphosphorylation through GSK3

Keyphrases

• Glycogen Synthase Kinase 3 (GSK3) 100%
• Tau Hyperphosphorylation 100%
• Zinc 80%
• Knockdown 40%
• Protective Behavior 40%
• Neurofibrillary Tangles 40%
• Activity-dependent Neuroprotective Protein 40%
• Intoxication 40%
• 3T3 Fibroblasts 40%
• Zinc Toxicity 40%
• Tau Kinases 40%
• Alzheimer's Disease 20%
• Increased Activity 20%
• Synaptic Dysfunction 20%
• Insults 20%
• High Concentration 20%
• Overexpression 20%
• Protective Effect 20%
• Dementia 20%
• Microtubules 20%
• Most Common Form 20%
• Protein S Deficiency 20%
• Neuronal Loss 20%
• Active Form 20%
• PC12 Cells 20%
• Tau Phosphorylation 20%
• PC12 20%
• Tau Aggregation 20%
• Structure Formation 20%
• Derived Peptide 20%
• Neuroprotective Properties 20%
• Zinc Concentration 20%
• Pheochromocytoma Cells 20%
• RNA Silencing 20%
• Tau Toxicity 20%
• Tau Expression 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Glycogen Synthase Kinase 3 100%
• Neuroprotective Agent 75%
• Toxic Injury 50%
• Neurofibrillary Tangle 50%
• Zinc Toxicity 50%
• Alzheimer's Disease 25%
• Phosphotransferase 25%
• Pheochromocytoma 25%
• Protein Deficiency 25%
• Protein Kinase Fyn 25%

Biochemistry, Genetics and Molecular Biology

• Hyperphosphorylation 100%
• Tau 100%
• Glycogen Synthase Kinase 3 33%
• Neurofibrillary Tangle 16%
• Zinc Toxicity 16%
• Kinase 8%
• Phosphotransferase 8%
• Fibroblast 8%
• Zinc 8%
• RNA Interference 8%